Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats
Open Access
- 14 February 2013
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 11 (1), 40
- https://doi.org/10.1186/1479-5876-11-40
Abstract
Background Left ventricular (LV) remodeling following large transmural myocardial infarction (MI) remains a pivotal clinical issue despite the advance of medical treatment over the past few decades. Identification of new medications to improve the remodeling process and prevent progression to heart failure after MI is critical. Thyroid hormones (THs) have been shown to improve LV function and remodeling in animals post-MI and in the human setting. However, changes in underlying cellular remodeling resulting from TH treatment are not clear. Methods MI was produced in adult female Sprague–Dawley rats by ligation of the left descending coronary artery. L-thyroxine (T4) pellet (3.3 mg, 60 days sustained release) was used to treat MI rats for 8 weeks. Isolated myocyte shape, arterioles, and collagen deposition in the non-infarcted area were measured at terminal study. Results T4 treatment improved LV ±dp/dt, normalized TAU, and increased myocyte cross-sectional area without further increasing myocyte length in MI rats. T4 treatment increased the total LV tissue area by 34%, increased the non-infarcted tissue area by 41%, and increased the thickness of non-infarcted area by 36% in MI rats. However, myocyte volume accounted for only ~1/3 of the increase in myocyte mass in the non-infarct area, indicating the presence of more myocytes with treatment. T4 treatment tended to increase the total length of smaller arterioles (5 to 15 μm) proportional to LV weight increase and also decreased collagen deposition in the LV non-infarcted area. A tendency for increased metalloproteinase-2 (MMP-2) expression and tissue inhibitor of metalloproteinases (TIMPs) -1 to −4 expression was also observed in T4 treated MI rats. Conclusions These results suggest that long-term T4 treatment after MI has beneficial effects on myocyte, arteriolar, and collagen matrix remodeling in the non-infarcted area. Most importantly, results suggest improved survival of myocytes in the peri-infarct area.This publication has 47 references indexed in Scilit:
- MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure*Archives of Physiology and Biochemistry, 2010
- Physiological Replacement of T 3 Improves Left Ventricular Function in an Animal Model of Myocardial Infarction-Induced Congestive Heart FailureCirculation: Heart Failure, 2009
- Rebuilding the post-infarcted myocardium by activating ‘physiologic’ hypertrophic signaling pathways: the thyroid hormone paradigmHeart Failure Reviews, 2008
- Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in ratsBasic Research in Cardiology, 2008
- Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial windowCardiovascular Research, 2006
- Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in MiceThe American Journal of Pathology, 2005
- Proangiogenic Action of Thyroid Hormone Is Fibroblast Growth Factor–Dependent and Is Initiated at the Cell SurfaceCirculation Research, 2004
- Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted ratCardiovascular Research, 2000
- Effects of 10- to 12-day treatment with L-thyroxine in rats with myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1988